[1]刘德鑫,李华东,李新丰,等.肝动脉栓塞化疗联合射频及无水乙醇注射治疗中晚期肝癌的评价[J].介入放射学杂志,2009,(05):389.
　LIU De-xin,LI Hua-dong,LI Xin-feng,et al.Evaluation of TACE combined with RFA and PEI in treating advanced hepatic carcinoma[J].journal interventional radiology,2009,(05):389.
点击复制

肝动脉栓塞化疗联合射频及无水乙醇注射治疗中晚期肝癌的评价()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2009年05期
页码:
389
栏目:
临床研究
出版日期:
2009-05-15

文章信息/Info

Title:
Evaluation of TACE combined with RFA and PEI in treating advanced hepatic carcinoma
作者:
刘德鑫; 李华东; 李新丰; 等
３６２０００福建泉州福建医科大学附属第二医院放射科（刘德鑫、李华东、李平），肝胆外科（李新丰、叶超平），超声介入科（吕国荣）
Author(s):
LIU De-xin; LI Hua-dong; LI Xin-feng; L譈Guo-rong; YE Chao-ping; LI Ping．
Department of Radiology，Second Affiliated Hospital，Fujian Medical University，Quanzhou３６２０００，China
关键词:
中晚期肝癌; 肝动脉化疗栓塞; 射频消融; 无水乙醇
分类号:
R７３５.７
文献标志码:
A
摘要:
目的探讨肝动脉化疗栓塞（TACE）联合射频消融（RFA）及无水乙醇注射（PEI）治疗中晚期肝癌的评价。方法７８例中晚期肝癌患者随机分为联合组（３９例）和对照组（３９例），联合组行序贯TACE→RFA＋PEI→TACE治疗，对照组仅行TACE治疗２～５次。治疗１个月后全部病例复查肝脏彩色多普勒超声、CT，观察患者肿瘤缩小程度、甲胎蛋白水平变化和随访１、２年生存率。结果联合组甲胎蛋白转阴率，肿瘤缩小率及１、２年生存率分别为８１．３％、８７．２％、９７．４％、７６．９％，明显高于对照组的５６．３％、６４．１％、７９．５％、５３．８％（P值均＜０．０５）。结论TACE联合RFA及PEI治疗中晚期肝癌安全有效，可明显改善疗效并延长生存期。

参考文献/References:

［１］王悦华，刘永雄．原发性肝癌的分期，根治切除标准及预后指标［J］．中华肝胆外科杂志，２００３，９：３-７．
［２］Goldberg SN，Ahmed M．Minimally invasive image-guide therapies for hepatocellular carcinoma［J］．J Clin Gastroenterol，２００２，３５：S１１５-S１２９．
［３］王建华，王小林，颜志平，等．腹部介入放射学［M］．上海：上海医科大学出版社，１９９８：６３．
［

相似文献/References:

[1]陆骊工,胡宝山,李勇,等.中晚期原发性肝癌合并症的介入治疗研究[J].介入放射学杂志,2008,(07):514.
　LU Ligong,HU Baoshan,LI Yong,et al.Study of interventional therapy for complications in advanced primary hepatocellular carcinoma[J].journal interventional radiology,2008,(05):514.
[2]李晓光,金征宇,潘杰,等.肝动脉化疗或栓塞治疗胰腺神经内分泌肿瘤肝转移的疗效分析[J].介入放射学杂志,2010,(06):442.
　LI Xiaoguang,JIN Zhengyu,PAN Jie,et al.Hepatic transarterial chemoperfusion and chemoembolization for the treatment of liver metastases from pancreatic neuroendocrine tumors：a therapeutic analysis[J].journal interventional radiology,2010,(05):442.
[3]王希锐,姜旭,潘波,等.分段栓塞治疗中晚期肝癌[J].介入放射学杂志,1997,(04):230.
[4]吴纪瑞,杨永岩,杨熙章,等.丝裂霉素C微囊肝动脉化疗栓塞术治疗中晚期肝癌[J].介入放射学杂志,1992,(01):41.
[5]杨学东,张志良,马戈,等.肝动脉化疗栓塞与三维立体定向放疗配合治疗原发性肝癌[J].介入放射学杂志,2009,(03):193.
　YANG Xuedong,ZHANG Zhiliang,MA Ge,et al.Hepatic arterial chemoembolization combined with３D conformal radiotherapy for primary hepatic carcinoma[J].journal interventional radiology,2009,(05):193.
[6]郑加生,李建军,崔雄伟,等.肝动脉化疗栓塞联合CT引导下射频消融术治疗肝癌的疗效分析[J].介入放射学杂志,2009,(05):324.
　ZHENG Jia-sheng,LI Jian-jun,CUI Xiong-wei,et al.Therapeutic combination of hepatic arterial chemoembolization with CT鄄guided radiofrequency ablation for hepatocellular carcinoma：an analysis of curative effect[J].journal interventional radiology,2009,(05):324.
[7]周怡婷,曹建民,许健,等.氩氦刀联合栓塞化疗治疗中晚期肝癌的临床研究[J].介入放射学杂志,2009,(10):733.
　ZHOU Yiting,CAO Jianming,XU Jian,et al.Cryotherapy combined with chemoembolization for the treatment of advanced hepatic carcinoma ：a clinical study[J].journal interventional radiology,2009,(05):733.
[8]纪昌学,陈宪,涂蓉,等.经肝动脉化疗栓塞对高危因素肝癌的疗效观察[J].介入放射学杂志,2007,(06):378.
　JI Chang-xue,CHEN Xian,TU Rong,et al.Therapeutic efficacy of transcatheter arterial chemoembolization for liver cancer with high-risk factors[J].journal interventional radiology,2007,(05):378.
[9]陈世,尹国文,徐卫东,等.超声引导下经皮射频消融治疗中晚期肝癌的临床研究[J].介入放射学杂志,2008,(01):37.
　CHENG Shixi,YING Guowen,XU Weidong,et al.Clinical research on advanced liver cancer treated with percutaneous RFA cool－tip electrode under ultrasound guidance[J].journal interventional radiology,2008,(05):37.
[10]陆阳,汤蕊嘉,谢璇丞,等.TACE联合阿帕替尼治疗中晚期肝细胞癌无进展生存时间的影响因素分析 [J].介入放射学杂志,2020,29(03):246.
　LU Yang,TANG Ruijia,XIE Xuancheng,et al.Analysis of influencing factors of progression-free survival in patients with advanced HCC treated with TACE combined with apatinib[J].journal interventional radiology,2020,29(05):246.

备注/Memo

备注/Memo:
收稿日期：２００８-１２-０３
更新日期/Last Update: 2009-05-15